Rex Bionics

Rex Bionics is a New Zealand-based company focused on developing robotic exoskeletons to enhance mobility for individuals who are wheelchair-bound. Founded in 2003 by robotics engineers Richard Little and Robert Irving, the company has grown from a small workshop idea into a publicly listed technology business on the London AIM Stock Exchange. The main product, the REX robotic exoskeleton, is a hands-free, wearable suit that allows users with lower limb disabilities to stand, walk, and engage in physiotherapy exercises. It is designed for individuals with conditions like multiple sclerosis, spinal cord injuries, and muscular dystrophy, promoting independence and mobility. The REX exoskeleton also supports Robot-Assisted Physiotherapy (RAP), enabling patients to transition from sitting to standing and participate in guided exercises. Rex Bionics serves individuals with mobility impairments, rehabilitation centers, and healthcare providers. The company is expanding its market reach internationally, including locations like Hong Kong and mainland China. With a team of around 32 employees, Rex Bionics is committed to improving the quality of life for wheelchair users through innovative exoskeleton technology.

• Employees 13
• Founded 2003
• Annual Revenue $140000